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Determining the structures of amyloid fibrils is an
important first step toward understanding the mole-
cular basis of neurodegenerative diseases. For
b-amyloid (Ab) fibrils, conventional solid-state NMR
structure determination using uniform labeling is
limited by extensive peak overlap. We describe the
characterization of a distinct structural polymorph
of Ab using solid-state NMR, transmission electron
microscopy (TEM), andRosettamodel building. First,
the overall fibril arrangement is established using
mass-per-length measurements from TEM. Then,
the fibril backbone arrangement, stacking registry,
and ‘‘steric zipper’’ core interactions are determined
using a number of solid-state NMR techniques on
sparsely 13C-labeled samples. Finally, we perform
Rosetta structure calculations with an explicitly
symmetric representation of the system. We demon-
strate the power of the hybrid Rosetta/NMR
approach by modeling the in-register, parallel
‘‘Iowa’’ mutant (D23N) at high resolution (1.2A˚ back-
bone rmsd). The final models are validated using an
independent set of NMR experiments that confirm
key features.
INTRODUCTION
The deposition of amyloid fibrils is a crucial clinical hallmark of
a variety of fatal neurodegenerative diseases, including Alz-
heimer’s disease (AD), Huntington’s, and Parkinson’s disease
(Chiti and Dobson, 2006; Selkoe, 1991; Siepe et al., 2012). Spe-
cifically for AD, formation of b amyloid (Ab) fibrils and various
oligomers consisting of the 40- or 42-residue Ab peptides (Ab1–
40 or Ab1–42, respectively), correlates with disease progression
and has been shown to be toxic to neuron cell cultures (Kayed
et al., 2003; Petkova et al., 2005). The Ab1–40 and Ab1–42 seg-
ments are derived from the enzymatic cleavage of larger amyloid
precursor proteins (APPs) (Barrett et al., 2012; O’Brien and
Wong, 2011), and single point mutations of the APP locus are
usually associated with familial, early-onset AD (Karran et al.,216 Structure 23, 216–227, January 6, 2015 ª2015 Elsevier Ltd All rig2011). Characterization of the high-resolution structures of Ab
fibrils has two important impacts to the field of AD. First, it
provides crucial information on the molecular mechanism of Ab
amyloid formation process, which is believed to disrupt normal
neuronal functions and elicit toxicity (Mason et al., 1996, 1999;
Peters et al., 2009; Widenbrant et al., 2006). Second, atomic
models could serve as templates for the development of mole-
cules targeting fibril structures, which is one of the clinically
tested therapeutic strategies to combat AD (Ladiwala et al.,
2012; Petrassi et al., 2000; Sievers et al., 2011).
Biochemical and biophysical characterizations of Ab fibril
structures have been performed extensively during the past
two decades (Antzutkin et al., 2000, 2002; Balbach et al., 2000;
Benzinger et al., 1998; Bertini et al., 2011; Lansbury et al.,
1995; Lu et al., 2013; Paravastu et al., 2008; Petkova et al.,
2002, 2006; Qiang et al., 2012; Tycko et al., 2009). These studies
typically use aqueous buffers to mimic physiological conditions
(pH, temperature, and salt concentration) and therefore serve
as good in vitro model systems for Ab fibrils formed around neu-
rons. The sequences of Ab1–40 and Ab1–42 contain two ‘‘amyloi-
dogenic’’ regions at residues 10–22 and 30–40(42) that may
form parallel or antiparallel b sheet structures due to their high
hydrophobicity (Tycko, 2011). These b sheet structures propa-
gate along themain axis of the fibril, resulting in the characteristic
cross-b pattern that is observed in diffraction studies of amyloids
(Sunde et al., 1997). An early study by Lansbury et al. (1995)
demonstrated that the C-terminal segment of Ab (named Ab34–
42) produces amyloid fibrils with an antiparallel b sheet structure.
X-ray crystallography conducted on a number of short Ab seg-
ments (6–8 residues) revealed a polymorphic group of primarily
antiparallel b sheet structures, and further highlighted the impor-
tance of a ‘‘steric zipper’’ motif, formed by intercalated side
chains of hydrophobic residues, in stabilizing the core of the fibril
structure (Colletier et al., 2011; Sawaya et al., 2007). However,
the longer Ab10–35 segment may also form parallel, in-register b
sheet structures (Benzinger et al., 1998). Several studies
focusing on Ab1–40 or Ab1–42 have suggested that the parallel
in-register structures are the main species of full-length Ab fibrils
(Bertini et al., 2011; Lu et al., 2013; Luhrs et al., 2005; Paravastu
et al., 2008; Petkova et al., 2002, 2006). These full-length
structures have been proven nonamenable to X-ray diffraction
studies, presumably due to the presence of flexible N-terminal
and loop segments (residues 1–15 and 23–29) that limit the
formation of a well-ordered crystal lattice. Solid-state nuclearhts reserved
Structure
Rosetta Modeling of b Amyloid Fibril Structuresmagnetic resonance (NMR) spectroscopy provides a powerful
alternative to crystallography for these challenging systems,
and several structural models of Ab1–40 fibrils have been deter-
mined using a variety of solid-state NMR experiments (Tycko,
2011). These studies revealed a highly diverse range of fibril
structures, suggesting that the amyloid state is not uniquely
defined by the amyloidogenic sequence, but it is dependent on
the precise fibril growth conditions. The types of models that
are consistent with the solid-state NMR data include different
numbers of cross-b subunits, packing arrangements, and
b-stand variations (Lu et al., 2013; Paravastu et al., 2008;
Petkova et al., 2006; Qiang et al., 2012). An extreme case of
such structural variability is the ‘‘Iowa’’ mutant of Ab1–40, consist-
ing of a single amino acid mutation (D23N) that forms mixtures
of parallel in-register and antiparallel b sheet fibril structures
under physiological buffer conditions, as shown previously by
solid-state NMR (Qiang et al., 2012; Tycko et al., 2009). Separa-
tion of pure samples of either parallel or antiparallel fibrils was
previously achieved using differences in seeding and elongation
kinetics between the two species. The antiparallel structure has
been shown to be a neurotoxic metastable intermediate (Qiang
et al., 2012), suggesting that the interplay between different fibril
polymorphs in the brain may have important implications in the
progression of familial AD.While amodel of the antiparallel struc-
ture was previously determined using extensive solid-state NMR
restraints from multiple isotopic labeling samples, the parallel
structure remains to date.
Given the established polymorphic nature of Ab1–40 fibrils, the
availability of detailed structural information would provide the
missing link between the observed differences in toxicity and
aggregation propensity with atomic features at the molecular
level (Petkova et al., 2005). While solid-state NMR has emerged
as a powerful technique for providing structural models of
amyloid fibrils, high-resolution structure determination typically
relies on the collection of a large number of experimental
restraints under multiple isotopic labeling schemes that make
conventional methods cumbersome. Moreover, due to the pres-
ence of alterative fibril symmetries, it is difficult to know a priori
what types of experimental restraints are needed to unambigu-
ously determine a structure, or alternatively to assess the range
of models consistent with the (sparse) experimental data.
A number of approaches have been applied to model amyloid
fibril structures. The first high-resolution structural model for the
40-residue Ab fibrils (Petkova et al., 2006) was generated using a
combination of MOLMOL and TINKER. In that study, comple-
mentary experimental constraints were obtained from five scat-
tering uniformly labeled peptides that covered residues 9–40
of the Ab sequence. Structural modeling was carried out using
molecular dynamics (MD) simulations and energy minimization.
Other high-resolution Ab fibril models, such as the three-fold
symmetric 40-residue Ab fibril (Paravastu et al., 2008) and the
antiparallel D23N Ab mutant fibril (Qiang et al., 2012), were
generated using similar protocols within the programs AMBER
(Cornell et al., 1995) and Xplor-NIH (Schwieters et al., 2003).
Structural modeling of Ab fibrils generated frompurified peptides
with uniform 13C, 15N isotope labeling has also been performed
on both in vitro (Bertini et al., 2011) and brain-seeded fibrils
(Lu et al., 2013). More abundant experimental constraints
were obtained using the uniformly labeled fibril samples, whichStructure 23, 21facilitated the computational modeling. In addition, a structural
model for the 42-residue Ab fibril was obtained from hydrogen/
deuterium exchange data recorded on 15N-uniformly labeled
samples (Luhrs et al., 2005) using CYANA (Guntert, 2004).
Here, we describe a modeling approach using the program
Rosetta (Leaver-Fay et al., 2011) to model amyloid fibrils from
a limited data set of solid-state NMR chemical shifts and dis-
tance restraints recorded on sparsely labeled samples. Rosetta
modeling has been previously applied to the core HET-s fibrils
based on NMR chemical shifts (Skora and Zweckstetter, 2012).
Here, alternative fibril arrangements are identified directly on
the basis of the experimental data and evaluated explicitly using
Rosetta’s symmetric modeling framework, allowing for optimal
conformational sampling of models under a previously estab-
lished set of symmetry parameters. The need for extensive
restraint data sets is alleviated through the use of a physically
realistic energy function. Instead, the sparse NMR data are
applied as a means of limiting the global search in areas of
conformational space that are close to the correct structure,
while the atomic details in the final models are largely defined
through a local optimization of the Rosetta energy function. As
a result, the final structures display realistic interfaces between
monomeric subunits and good structural statistics. We generate
a high-resolution fibril model for the parallel, in-register Iowa
(D23N) mutant of Ab1–40 using this approach. For this specific
familial mutant of Ab, the only reported fibril structure to date
shows an antiparallel arrangement (Qiang et al., 2012). The final
models show a reduced steric zipper core and a well-defined
loop conformation relative to the mature wild-type fibrils and
therefore provide a high-resolution view of an important toxic
polymorph to understand the interplay between structure and
disease progression for this familial AD.
RESULTS
Ab1–40 D23NForms aMixture ofMorphologically Distinct
Fibrils Grown under the Same Experimental Conditions
The experimental procedure used to obtain homogeneous paral-
lel D23N Ab1–40 fibrils is outlined in Figure 1A. Starting from an
initial mixture containing both parallel and antiparallel fibrils, we
took advantage of previously observed differences in nucleation
and elongation kinetics between the two species (Qiang et al.,
2012). In particular, the antiparallel fibrils show faster nucle-
ation/slower elongation phases relative to the parallel fibril spe-
cies. First, we generated a mixture of short fibril fragments, of
approximately 50–100 nanometers (nm) in length by sonication.
We then added an excess of monomeric D23N Ab1–40 peptides,
leading to seeded fibril growth using the initial short fragments
as templates. We have previously shown that the antiparallel
fibril structure can be isolated using a similar iterative filtration/
generation seeding protocol (Qiang et al., 2012). The key step
in that study was to separate the antiparallel fibril from other
components in the mixture based on its distinct size. Here, we
used fast generation seeding protocols involving repeated
sonication and incubation cycles in a relatively short time course
to selectively amplify the kinetically favored parallel structure.
Figure 1B shows a representative transmission electron micro-
scopy (TEM) image obtained for the parallel fibrils after 8-cycles
of fast generation seeding. The filaments display a uniform long6–227, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 217
Figure 1. Preparation and TEM Character-
izations of the Parallel Iowa Mutant Fibrils
(A) Scheme for purifying the mixture of D23N
Ab1–40 fibrils that contain both parallel (red) and
antiparallel (green) structures. The detailed pro-
tocols are (a) sonication for 2 min in ice bath, (b)
quiescent incubation at 4C for 4 hr, (c) repetition
of the steps (a) and (b), (d) filtration with 0.22 mm
filter, and (e) quiescent incubation 4C for 24 hr.
(B) Negatively-stained TEM image of the parallel
D23N Ab1–40 fibril.
(C) Tilted-beam TEM image of D23N Ab1–40 fibril
for MPL measurement. Arrows indicate images of
fibrils.
(D) Histogram of the mass-per-length (MPL) dis-
tribution of parallel D23N Ab1–40 fibril. The plot was
generated based on 300 individual MPL mea-
surements. The distribution fit to a single Gaussian
function with the peak value n = 3, indicating a
bundle of three cross-b subunits per layer.
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and curvy morphology of previously identified antiparallel D23N
Ab1–40 fibrils (Qiang et al., 2012). In addition, this morphology
is clearly distinct from the two most commonly observed
morphologies of wild-type Ab1–40 fibrils, named twisted sheet
and striated ribbon (Paravastu et al., 2008; Petkova et al.,
2006). The majority of filaments were single and unbundled,
with rough surfaces and irregular twisting. These novel features
suggest that the underlying atomic structure of D23N fibrils is
also distinct from wild-type Ab1–40, consistent with our previous
observation that there was no cross seeding effect between
D23N mutant and wild-type fibrils (Qiang et al., 2012).
A representative tilted-beam TEM image and derived mass-
per-length histogram are shown in Figures 1C and 1D, respec-
tively. Together with the established regular symmetry by NMR
(as outlined in the following section), these results suggest a
three-fold symmetry axis (N = 3 subunits/layer) for the parallel
D23N Ab1–40 fibrils, where each filament is a bundle of three
cross-b subunits. The apparent distribution range from 2–4
subunits per layer in Figure 1D is likely due to background
scattering in the dark field images (Lu et al., 2013). We have pre-
viously shown that antiparallel D23N fibrils formed under the
same experimental conditions display a primarily single-layer
structure, suggesting that the antiparallel fibril is a metastable
intermediate rather than a mature fibril (Qiang et al., 2012).
On the other hand, the parallel fibrils studied here contain multi-218 Structure 23, 216–227, January 6, 2015 ª2015 Elsevier Ltd All rights reservedple subunits, which is a common feature
of mature Ab fibrils formed by the wild-
type peptides (Lu et al., 2013; Paravastu
et al., 2008; Petkova et al., 2006).
The Backbone Conformations
of D23N Ab1–40 in Parallel
and Antiparallel Fibrils
Are Highly Similar
As a probe of the local secondary struc-
ture of parallel D23N Ab1–40 fibrils, we
measured backbone 13C chemical shifts.We used the finite-pulse radio frequency-driven recoupling
(fpRFDR) experiment to record 2D spectra for a series of Ab
fibril samples prepared with the scattering uniformly labeling
approach that involves isotopic labeling for at most one residue
in the polypeptide sequence per amino acid type. This labeling
scheme (Figure 2A) was necessary to reduce spectral overlap,
while still providing a sufficient number of labeled sites in the
two commonly observed hydrophobic core regions of Ab.
A representative 2D 13C-13C correlation spectrum is shown in
Figure 2B. Most of the labeled residues show only one set of
crosspeaks, with the exception of G29 and A30, which have
one major and one minor component. This observation sug-
gests that, after eight cycles of generation seeding, the sample
becomes highly homogeneous and further highlights the pres-
ence of regular symmetry in the fibril structure (i.e., an identical
chemical environment for all equivalent Ab subunits). Inspection
of the secondary chemical shift values (Wishart et al., 1995)
suggests that there are two well-defined b strands, spanning
residues K16–A21 and A30–V36 (Figure 2C). The chemical
shifts of V39 are also consistent with a b strand conformation.
However, the Ca/Cb crosspeak intensity is clearly weaker
relative to other residues, suggesting that there may be more
motion within the C-terminal region (Figure 2B). Similar to the
previously determined antiparallel D23N Ab1–40 fibril (Qiang
et al., 2012), the parallel fibril shows a relatively shorter C-termi-
nal hydrophobic core region relative to the wild-type Ab fibrils,
Figure 2. Secondary Chemical Shifts for the
Parallel Iowa Mutant Fibrils
(A) Isotopic labeling schemes for the scattering
uniform labeled samples. The 13C, 15N-labeled
amino acids are shown in red. Fibril structures
were determined from NMR experiments on
samples (A–F). The labeling pattern shown in (G)
was synthesized to validate the structural model.
(B) The aliphatic region of a representative 2D
13C-13C fpRFDR spectrum (sample B) of the par-
allel D23N Ab1–40 fibril. The assignments of
different residues are shown with connections
between the corresponding crosspeaks.
(C) Plot of the secondary chemical shifts of the
isotopically labeled residues. For each residue,
the bars indicate Dd of C’, Ca, and Cb from left
to right, respectively. Based on the secondary
chemical shifts, the residues with typical b strand
secondary structure (negative C’, Ca, and positive
Cb) are shown in blue, while other residues are
shown in red.
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available online). This trend is also evident in the predicted
backbone torsion angles using TALOS+ (Table 1) (Shen et al.,
2009). The comparison between the backbone Ca and Cb
chemical shifts for parallel versus antiparallel D23N fibrils
suggested that the two species share a similar backbone
conformation, probably with the exception of E22, where the
parallel fibrils seem to adopt a more a-helical-like conformation
(Table S2).
The Parallel D23N Ab1–40 Fibrils Demonstrate
an Extended Hydrophobic Core Relative
to the Antiparallel Structure
We used a variety of solid-state NMRmethods to measure long-
range interactions, arising from contacts both within a single Ab
subunit and across different trimeric layers. Figures 3A and 3B
show the 13C-PITHIRDs-CT decay curves, which report on dis-
tances between specific labeled sites on adjacent monomers
along the fibril axis. The 13C isotopic label was placed on the
carbonyl carbons of V18 or M35, or the methyl carbons of A21
or A30. These residues are located within the b strand regions
according to the chemical shift analysis (Figure 2C). The decay
curves fit approximately to a 5.0 ± 0.3A˚ distance, which corre-
sponds to the expected distance between these atoms in an
ideal parallel, in-register b sheet structure (Figure 3C). The fact
that the experimental decay curves for all four sites are indistin-
guishable within the experimental uncertainty suggests that the
intersubunit b sheet pairing extends over the entire length of
the N- and C-terminal strands. This trend is clearly different
from the similar experiments performed previously using antipar-
allel D23N Ab1–40 fibrils, where similar labeling sites showed
much slower 13C-PITHIRDs-CT decay curves (Qiang et al.,
2012). Electron diffraction measurements on the parallel fibril
sample show a clear diffraction ring at 4.8 A˚, further indicating
a strong cross-b fibril structure in agreement with the NMR
results (Figure S2).Structure 23, 21We then recorded radio frequency assisted diffusion (RAD)
spectra reporting on long-range 13C-13C internuclear distances
between 3–7 A˚ (Figure 4). A commonly observed structural motif
in amyloid fibrils is the ‘‘U-like’’ conformation, where the two
sequential b strands are packed against each other forming a
steric-zipper core of hydrophobic side-chain contacts (Sawaya
et al., 2007). Comparison between fully labeled and diluted
samples (shown in Figures 4A and 4B, respectively) suggests
that, in the D23N Ab1–40 fibrils used here, such interactions are
not intramolecular, but intermolecular (Petkova et al., 2006).
For the diluted samples, the fibrils were prepared using the
same procedure, but with a 5:1 molar ratio of supplied unlabeled
and labeled Ab peptides in order to suppress intermolecular
contacts between the labeled sites. Representative slices in
Figure 4E show that the interactions between the aromatic
carbons of F19 to L34 Cg and A21 Ca to I32 Cg1 were signifi-
cantly attenuated in the diluted sample, suggesting the presence
of an intermolecular polarization transfer pathway. In particular,
these interactions are likely formed between the N-terminal b
strand (K16–A21) of one monomer and the C-terminal strand
(A30–V36) of the adjacent monomer along the fibril axis. Further-
more, we observed that most of the intraresidue crosspeaks
for I32 were eliminated in the diluted samples. However, similar
effects were not detected for residues F19, A21, and L34, sug-
gesting that the I32methyl carbonsmay have shorter spin-lattice
relaxation time values such that the signal is attenuated during
the long RAD mixing period. The same effect was not observed
in experiments recorded for the undiluted sample, likely due to
the presence of additional labeling sites near I32 that may restore
the signal through polarization transfer. Additional RAD spectra
allowed the identification of an unusual long-range contact be-
tween L17 and V36 (Figure S3), suggesting that the hydrophobic
core of the parallel fibril structure is more extended relative to the
antiparallel fibril (Qiang et al., 2012), but less extended than in
wild-type fibrils, where the C-terminal b sheet reaches the end
of the polypeptide chain (Petkova et al., 2006).6–227, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 219
Table 1. Chemical Shifts of the Parallel D23N Ab1–40 Fibril and the Predicted Backbone Torsion Angles Using TALOS+
Residues C (ppm) Ca (ppm) Cb (ppm) Cg (ppm) Cd (ppm) Cε/Cz (ppm) Torsion Angles (F,4)
K16 172.9 (174.9)a 52.2 (54.5) 34.5 (31.4) 23.8 27.8 39.9 (Cε)
L17 175.1 (175.9) 52.0 (53.4) 43.1 (40.7) 26.3 23.1 (d1, d2)b 110.8 (14.3), 124.5 (7.6)c
F19 173.8 (174.1) 52.9 (56.0) 41.9 (37.9) 128.5 (Cz) 119.0 (13.6), 146.6 (12.6)
F20 173.6 (174.1) 52.8 (56.0) 42.7 (37.9) 128.9 (Cz) 130.0 (11.4), 147.8 (12.9)
A21 175.0 (176.1) 48.0 (50.8) 21.3 (17.4) 131.1 (16.2), 141.1 (14.1)
E22 174.5 (174.9) 57.6 (54.9) 29.1 (28.2) 33.0 180.3 81.8 (15.9), 28.0 (8.4)
N23 173.8 (173.5) 51.0 (51.4) 41.0 (37.2) 177.2 111.4 (36.6), 149.3 (12.4)
V24 174.8 (174.6) 60.8 (60.5) 33.4 (31.2) 18.0 (g1) 16.5 (g2)
K28 174.8 (174.9) 55.9 (54.5) 33.4 (31.4) 25.3 29.4 40.2
G29 171.2 (173.2) 43.8 (43.4) 112.1 (67.4), 129.7 (32.9)
A30 174.7 (176.1) 47.3 (50.8) 19.2 (17.4) 127.4 (17.3), 146.6 (15.3)
I31 174.0 (174.7) 57.2 (59.4) 38.8 (37.1) 24.7 (g1), 17.1 (g2) 12.2 120.1 (11.4), 127.9 (6.0)
I32 173.9 (174.7) 56.1 (59.4) 40.5 (37.1) 24.8 (g1), 15.7 (g2) 11.4 122.0 (12.5), 148.9 (15.7)
G33 170.9 (173.2) 42.4 (43.4) 125.5 (16.5), 147.2 (13.6)
L34 174.8 (175.9) 51.5 (53.4) 43.6 (40.7) 24.3 21.0 (d1, d2) 118.0 (12.5), 129.4 (12.2)
M35 172.7 (174.6) 51.3 (53.7) 34.0 (31.2) 30.5 127.6 (17.2), 132.8 (10.8)
V36 174.4 (174.6) 58.3 (60.5) 33.0 (31.2) 19.6 (g1) 17.8 (g2) 120.2 (16.4), 137.8 (20.3)
G37 171.4 (173.2) 43.7 (43.4) 171.9 (65.6), 172.2 (24.8)
G38 169.7 (173.2) 42.3 (43.4) 126.1 (21.5), 144.0 (12.5)
V39 172.9 (174.6) 58.2 (60.5) 32.4 (31.2) 19.3 (g1 and g2) 124.5 (25.7), 134.5 (21.1)
V40 169.0 (174.6) 60.0 (60.5) 33.9 (31.2) 20.4 (g1 and g2)
aChemical shift values for the random coil conformation.
bThe peaks for Cg1 and Cg2 were not resolved in NMR spectrum. Similar signal overlapping was observed for the side chains of L34, V39, and V40.
cUncertainty given by the TALOS+ program.
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gions provide additional information toward deriving atomic
models of fibril structures. The loop region (E22–G29) is highly
ordered according to the observed NMR line widths (i.e.,
200 Hz) that are similar as for residues in the b strand regions.
Figures 4C and 4D show an important interaction in this region,
as revealed by multiple crosspeaks. Several 13C nuclei along
the K28 side chain are in close proximity with the CO and Cb
of theC-terminal V40. However, a possible salt bridge interaction
between the Nε of K28 and CO of V40 was not observed in addi-
tional NMR experiments (Figure S4A), suggesting that the side
chain of K28 is likely to be solvent-exposed. Similar interactions
between K28 and V40 were observed for the antiparallel D23N
Ab1–40 fibril, but not for fibrils formed by wild-type Ab (Paravastu
et al., 2008; Qiang et al., 2012). Notably, several wild-type Ab
fibrils show a salt bridge contact between D23 and K28, sug-
gesting that the side chain of K28 is oriented toward the hydro-
phobic core of the fibril (Ahmed et al., 2010; Lu et al., 2013;
Petkova et al., 2006). Therefore, the single D23N mutation likely
affects the local backbone torsion angles in the loop region
causing a side-chain flip for K28, a residue that has been pro-
posed to play an important role during the initial steps of the fibril
formation process (Reddy et al., 2009; Tarus et al., 2006). To
further verify the absence of N23/K28 interaction in the mutant
fibril, we performed additional 15N-13C rotational-echo double
resonance experiments on the residue pairs N23 C’/K28 Cε
and N23 Cg/K28 Cε. The negative results shown in Figure S4B
indicated that these sites are in the fibril structure.220 Structure 23, 216–227, January 6, 2015 ª2015 Elsevier Ltd All rigStructure Modeling Using Rosetta Reveals a Staggered
b Sheet Arrangement and Extended Hydrogen Bond
Network Involving Asn23
To generate atomic models of the filament core structure, we
used an explicit Rosetta symmetric modeling framework (DiMaio
et al., 2011), further extended to fibril systems with additional
point symmetries. Starting from a fibril arrangement consisting
of nine trimers of Ab15–40 polypeptide chains in a fully extended
conformation, we optimized the total energy of the system,
including the solid-state NMR restraints, by simultaneously
sampling both the internal backbone degrees of freedom and
the six rigid body degrees of freedom defining the overall fibril
topology (Das et al., 2009). We used the conformation-depen-
dent chemical shifts to select 3- and 9-residue backbone frag-
ments from high-resolution structures in the Protein Data Bank
(PDB) that were then assembled into full Ab15–40 polypeptide
chains (Vernon et al., 2013). Backbone and rigid-body changes
were propagated among symmetry-related subunits, thus
limiting conformational search and energy evaluations to models
that are consistent with the overall symmetry of the system.
Finally, we used symmetric full-atom refinement to optimize
the placement of side-chain rotamers throughMonte-Carlo trials
and gradient-based minimization of all backbone, side-chain,
and rigid-body degrees of freedom. The weight of the solid-state
NMR restraints at this final refinement stage was reduced to 1/
10 of the original value, such that the final atomic features
of the models are defined according to a physically realistic all-
atom energy function (Leaver-Fay et al., 2011). The explicitlyhts reserved
Figure 3. PITHIRDs Measurements on Backbone Registry
(A and B) 13C PITHIRDS dephasing curves for selectively labeled sites in
parallel D23N Ab1–40 fibril. In (A) and (B), the error bars were estimated from the
spectral noises in the corresponding PITHIRDs spectra.
(A) Val18 CO and Ala21 CH3.
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Structure 23, 21symmetric representation of the system used here allows for a
tractable search of the six rigid-body degrees of freedom that
uniquely define a fibril arrangement in a systematic manner
(Figure S5).
The ten lowest-energymodels that show nomajor violations of
the solid-state NMR restraints were selected for deposition in
the PDB (PDB ID 2MPZ; Table 2). This final ensemble of models
is highly converged at the protofilament level (within 1.15/1.45 A˚
backbone heavy atom rmsd). The fold of individual subunits
consists of a typical b-loop-b structure, with the two b strands
spanning residues K16–N23 and A30–V36 (Figure 5A), consis-
tent with the Ca secondary chemical shift pattern (Figure 3C).
Notably, the core of the structure is stabilized by a steric zipper
motif formed between the side chains L17, F19, and A21 from
monomer i that interdigitate between the side chains of I32,
L34, and V36 from monomers i and i+3, thus explaining the
weakening of crosspeaks between these residues in the NMR
dilution experiments. When viewed alongside the fibril axis, adja-
cent Ab monomers display a staggered b pattern, allowing the
formation of the intra and intermolecular steric zipper (Figure 5B).
The staggered arrangement results from an axial displacement
of the outer b strand by 0.5 layers (+0.5) per subunit, which gives
rise to an intermolecular pattern of side-chain packing interac-
tions. The structure of the loop region at residues 24VGSNK29G
shows key side chain and hydrogen bonding features. In partic-
ular, while the side chains of N27 and K28 are oriented toward
the exterior of the structure, N23 and S26 are facing toward
the core of the fibril. In particular, N23 is forming a string of inter-
molecular hydrogen bonds parallel to the main axis of the fibril,
and S26 helps stabilize the loop conformation through a side-
chain-to-backbone hydrogen bond to the amide group of N27
(Figure 5C). The side-chain placement of the loop residues
were validated using additional solid-state NMR 2D 13C-13C
spin diffusion experiments with uniform labeling at residues
N23, S26, K28, A30, and V40, where strong crosspeaks were
observed between N23 and S26 as predicted by the Rosetta
models (Figure S6A). The new, high-resolution spectra further
confirmed the presence of multiple close contacts between
residues K28 and V40. For instance, the crosspeaks for the pairs
K28 Cε/V40 Cg, K28 Cd/V40 Cg, and K28 C’/V40 Cg can be as-
signed unambiguously (Figure S6B). Notably, the final structure
showed closer contacts between these additional nuclei pairs
than the contacts that were utilized as structural restraints (Table
S1). Contacts used in the Rosetta modeling typically had unam-
biguous assignments with high signal-to-noise ratio in the NMR
spectra. A few close contacts suggested by the structural model,
such as E22 Ca/A30 Cb, cannot be assigned due to signal over-
lap in the spectra nuclei pairs, including G29 Ca/N23 Cb and
G38 Ca/I31 Cg2, showed relatively weak crosspeaks and were
therefore not used as structural restraints.(B) Ala30 CH3 and Met35 CO. The theoretical dephasing curves calculated for
different internuclear distances are shown as dotted lines. All labeled residues
have dephasing curves that fit to 5 A˚ simulated distance.
(C) Schematic presentation of the parallel and antiparallel b sheet backbone
composed of residues 17–21. The amide N, Ca, and C’ were shown in blue,
black, and red, respectively. The dotted lines in the parallel scheme indicated
the interstrand distance of4.8 A˚ that can be detected using PITHIRDs (cf. A),
while the same antiparallel scheme was too long to be measured.
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Figure 4. Representative 2D 13C-13C RAD
Spectra
(A–D) The sample was prepared by diluting the
labeled Ab1–40 peptide with unlabeled peptide
in 1:5 molar ratio. The crosses in (B) indicate
that the F19/L34 and A21/I32 interactions missing
(A), suggesting that these crosspeaks result from
interstrand contacts.
(E) The intraresidue crosspeaks in the diluted
(green) and undiluted (red) specra were the same
intensity to facilitate the direct comparison for the
interresidue crosspeaks.
(F) Red arrows indicate important crosspeaks that
long-range restraints.
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Several studies focusing on structural characterization of Ab
fibrils have been carried out over the past two decades, with a
number of models proposed for fibrils of different lengths and
sequence mutations, under a range of experimental and sample
preparation conditions (Bertini et al., 2011; Lu et al., 2013; Luhrs
et al., 2005; Paravastu et al., 2008; Petkova et al., 2006; Qiang
et al., 2012). This body of work strongly suggests that different
Ab fibrils vary significantly in terms of their overall symmetry
parameters, the extent of the b sheet hydrophobic core, the222 Structure 23, 216–227, January 6, 2015 ª2015 Elsevier Ltd All rights reservedmain chain hydrogen bonding patterns,
and the detailed side-chain packing
interactions within the core steric zipper.
An important question is whether the
observed differences at the structure
level may lead to different toxicities,
tissue localization, or other functional
properties, as suggested by recent
studies using rat embryonic neurons (Pet-
kova et al., 2005). To address this funda-
mental problem, further development of
high-resolution structure determination
methods is required. Solid-state NMR is
a powerful technique to gain atomic-level
information on these insoluble, noncrys-
talline systems, however, the collection
of complete restraint data sets required
for conventional structure determination
protocols is often limited by spectral
overlap that reduces the number of well-
resolved resonances in the spectra of
fully labeled fibril samples.
Our modeling of the Iowa mutant Ab
fibril makes use of a combination
of solid-state NMR data recorded on
sparsely labeled samples with Rosetta
symmetric modeling, providing a good
example of obtaining high-resolution
structural models from limited experi-
mental restraints. Spectral overlap is
reduced using a sparse labeling
approach, with the introduction of 13C
and 15N labels at selected sites of theamino acid sequence. The method overcomes low restraint
count (cf. Figure S7, 1–2 experimental long-range restraints
per residue used in this study) by exploiting a physically realistic,
all-atom energy function that is sensitive to hydrogen bonding
and side-chain packing interactions. As a result, the final
models show realistic structural features at a resolution that is
significantly higher than can be afforded by the available exper-
imental data.
While the solid-state NMR backbone chemical shifts help
define the local backbone conformation and long-range pack-
ing interactions, an additional source of valuable structural
Table 2. Solid-State NMR Restraints and Structural Statistics
NMR Distance and Dihedral Angle
Restraints




Total dihedral angle restraintsc 44
F 22
J 22




Restraint violations (used/validation) 1/0
MOLPROBITY clashscore, all atomse 10.65
Average rmsd (A˚)c
Backbonef 1.2/1.5
All heavy atomf 1.9/2.2
aNumbers indicate the restraints used for structure calculation/validation.
bInferred from the combination of the cross-b diffraction patterns, the
backbone chemical shifts, and 13C-PITHIRDs-CT experiments.
cUsed to bias the selection of 3-mer and 9-mer backbone fragments,
as outlined in Experimental Procedures.
dComputed over the five lowest-energy structures.
eClashscore is the number of serious steric overlaps (>0.4 A˚) per 1,000
atoms.
fReported for a monomer/lateral dimer respectively, as outlined in
Figure 5.
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resonance for every labeled atom. Given the high degree of
sensitivity of the chemical shifts to the local conformation of
the polypeptide chain (Shen et al., 2009), this suggests that
the NMR sample consists of homogeneous fibrils at the
atomic level (consistent with the uniform appearance of fibril
morphologies under the electron microscopy [EM]), and
strongly supports the presence of regular symmetry in the fibril
structures, where adjacent Ab subunits have identical back-
bone dihedrals and side-chain rotamers. These symmetry
considerations provide an additional structural constraint that
reduces significantly the extent of conformational space to
be searched. Here, we exploit this information by using
an explicitly symmetric representation of the system that
further limits sampling to conformations that satisfy the
fibril and point symmetries of the system, as determined
experimentally from TEM mass-per-length measurements. In
summary, the use of an explicit representation of symmetry
significantly reduces the number of structural constraints
needed.
The overall organization of subunits around the 3-fold axis
of symmetry reveals a luminal orientation of the C-terminal b
strand at an intermediate resolution (backbone rmsd of 4.8 A˚,
computed along the 3-fold symmetry axis). While the sharp
resonances of residues involved in intermolecular contacts
along the 3-fold axis suggest the lack of conformational vari-Structure 23, 21ability, a number of possible rigid-body orientations are con-
sistent with the sparse solid-state NMR restraints. However,
the spectra clearly indicate multiple interactions between V40
and K28 that can only be satisfied by an intermolecular contact
between these residues. These restraints are sufficient to
obtain convergence on a bundle of subunits that interact
laterally through the loop and C-terminal regions facing the
center of the fibril, while the N-terminal b strand forms the
exterior of the fibril structure. Using the new Rosetta modeling
framework with additional structural restraints from solid-
state NMR and high-resolution cryo-EM density data will
enable a more rigid-body placement of the individual subunits
toward a complete atomic model of the higher-order fibril
structure.
Despite their common parallel b sheet arrangement and 3-fold
symmetry axis, our results show notable differences between
the D23N and wild-type Ab1–40 fibrils. A clear difference between
the two structures involves the size of hydrophobic core, i.e., the
number of residues that are involved in the b sheet regions. The
current model of the parallel D23N fibril structure shows a
smaller hydrophobic core, relative to the wild-type sequence,
that does not include residues G37–V40 and becomes further
reduced in the antiparallel structure for the same mutant (Qiang
et al., 2012). On the other hand, shorter segments of wild-type Ab
sequence with a much smaller hydrophobic core, containing
either the C- (K16–E22) or N-terminal (A30–V40) amyloidogenic
regions, form fibrils with predominantly antiparallel b sheet struc-
tures (Balbach et al., 2000; Lansbury et al., 1995). However, the
full-length wild-type Ab sequence forms exclusively parallel,
in-register b sheet fibrils with an extensive core region spanning
up to the C-terminal residue V40. Taken together, these results
suggest that Ab has a higher propensity to form antiparallel
fibrils as a result of sequence mutations that limit the size of
the hydrophobic core region. On the other hand, a parallel,
in-register b sheet arrangement is strongly favored by the optimi-
zation of hydrophobic interactions involving a more extended
steric zipper motif.
The availability of multiple Ab fibril structures now permits a
more complete characterization of the end-points of different
fibril formation pathways. Comparison of the three structures
(wild-type Ab, parallel, and antiparallel Ab D23N) suggests a cor-
relation between the D23N mutation, the luminal side-chain
orientation of K28, and the absence of C-terminal residues in
the hydrophobic core (Figure 6). While a stabilizing D23–K28
salt bridge is observed in the wild-type structure, in the D23N
mutant the hydrophobic core can no longer accommodate
the charged side chain of K28 that is now a solvent-exposed
orientation. Our NMR experiments did not directly verify the
formation of a stable K28–V40 salt bridge interaction, sug-
gesting that the charges of K28 and V40 are instead fully sol-
vated. However, our results do not exclude the possibility of a
transient electrostatic interaction between the two sites, espe-
cially at the early stages of fibril formation. Using saturation-
transfer NMR experiments reporting on fibril formation kinetics
in solution (Fawzi et al., 2012) and structural characterization
of the final fibril structures by solid-state NMR, the role of
different familiar AD sequence mutations in stabilizing distinct
metastable intermediates along the fibril formation pathway
can be achieved.6–227, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 223
Figure 5. Representative Structural Model
of the Parallel, In-Register Fibril of the
D23N Iowa Mutant of Ab
(A) Top view along the fibril and 3-fold symmetry
axes. The side chains of a single subunit are
shown, highlighting the steric-zipper core formed
by residues L17, F19, and A21 from the N-terminal
and I32, L34, and V36 from the C-terminal b
strands. The loop conformation shows a luminal
placement of residues N23 and S26, while N27
and K28 are oriented toward the solvent.
(B) Lateral view of a single cross-b subunit
extracted from the 3-fold bundle along the main
fibril axis. The staggered arrangement of b strands
from individual subunits and hydrogen-bonding
network formed by the side chain of N23 are
highlighted on the structure.
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Preparation of Parallel D23N Fibril Samples
D23N Ab1–40 was synthesized using solid phase peptide synthesis (Applied
Biosystems 433A automated peptide synthesizer) with fluorenylmethyloxy-
carbonyl chloride chemistry and purified by high-performance liquid chroma-
tography equipped with a C3 reverse phase column (Zorbax, Agilent), using a
H2O/acetonitrile gradient with 1.0% acetic acid. The mass of peptides was
verified by electrospray ionization mass spectrometry (1100 MSD, Hewlett-
Packard). The purified product (>95% p.m.) was lyophilized and stored
at 20C to prevent the oxidation and aggregation of monomer before
fibrillation.
Toward preparing parallel fibrils, the lyophilized peptide was first dissolved
in DMSO to a starting concentration of 5.0 mM, and the DMSO solution was
then diluted into phosphate buffer (10 mM, pH = 7.4, 0.01% NaN3) to a final
peptide concentration of 100 mM. This peptide solution was incubated at
4C for 1 week, until the formation of fibrils could be verified using negatively
stained TEM. We used a relatively lower temperature of 4C (comparing with
the ambient temperature or 37C) such that the experimental conditions were
consistent with those used previously to prepare antiparallel fibrils (Qiang
et al., 2012). After 1 week of incubation, 10% of the fibril solution was soni-
cated for 2 min on an ice bath to form seeds (i.e., short fibril fragments of
100 nm in length), and 100 mM fresh D23N Ab1–40 monomer solution was
added to the seeds. The mixture was then incubated at 4C for 4 hr to allow
the elongation of seeded fibrils, which was verified by TEM. This sonication-
incubation procedure was repeated for eight cycles, and the final product
was collected by ultracentrifugation (100,000 round-per-minutes, 432,000 3
g, Beckmann Coulter). As opposed to the protocol used previously to prepare
antiparallel D23N mutant fibrils (Qiang et al., 2012), the current procedure did
not involve the filtration step, which separated filaments based on their size.
By using a shorter incubation time during the repeated seeding, the current
protocol selectively amplifies filaments that elongate more rapidly (Qiang
et al., 2011).
TEM
TEM measurements were performed using an FEI Morgagni microscope,
operating at 80 kilovolts. To obtain each negatively stained TEM image, a
10 ml drop of 25 mM fibril solution was deposited onto a glow-discharged
carbon film, which was supported by lacey carbon on a 300 mesh copper
TEM grid. The fibril solution was absorbed for 2 min and then removed by
a tissue paper. The grid was then rinsed once with 10 ml of deionized water
and then stained with 10 ml of 2% uranyl acid for 30–40 s. The staining solution
was then removed, and the grid was dried in air before measurement. All
negatively stained TEM images were recorded using 89,0003 magnification.224 Structure 23, 216–227, January 6, 2015 ª2015 Elsevier Ltd All rights reservedFor mass-per-length (MPL) measurements (Chen
et al., 2009), a 5 ml drop of 10 mM fibril solution
was mixed with 5 ml of tobacco mosaic virus(TMV) solution (0.5 mg/mL in pH 8.0 Tris buffer). The mixture was deposited
on glow-discharged grid and absorbed for 2 min. The solution was removed
by tissue paper, and the grid was rinsed once with deionized water and
dried in the air before examination. Dark-field images were recorded using
44,0003magnification with a 1.2 tilt of the electron beam. The beam intensity
was adjusted so that there was a uniform illumination for each image field.
MPL values for individual fibrils were measured by quantification of relative
intensities of fibrils and TMV in 20 image fields. The fibril MPL values were
calibrated using the standard MPL value for TMV (131 kilodaltons/nm).
Solid-State NMR
For NMR measurements, D23N Ab1–40 fibrils pellets were collected from the
incubation solution using ultracentrifugation at 435,000 3 g and 4C for
60min. Thewet pellet was then freeze-dried, packed intomagic angle spinning
(MAS) rotors with additional Teflon spacers, and rehydrated with 1 mL/mg of
deionized water for NMR measurements.
Solid-state NMR measurements were performed at either 9.4 T (100.4 MHz
13C NMR frequency) or 14.1 T (150.6 MHz 13C NMR frequency) with a Varian
InfinityPlus spectrometer and a Varian 3.2 mm triple-resonance MAS probe,
or with a Bruker Avance III spectrometer and a 2.5 mm TriGammaMAS probe.
For all the experiments, the initial 13C signal was generated by a 90 1H flip
pulse followed by a 1H-13C cross polarization (CP) period. The 13C field during
CP was centered at 50 kHz with an adiabatic (on Varian spectrometer) or a
linear (on Bruker spectrometer) ramp of 25 kHz. The 1H field was optimized
accordingly for different experiments so that the Hartmann-Hahn condition
was always satisfied. For the fpRFDR experiments (Ishii, 2001), the mixing
period was set to 2.4 milliseconds (ms) and was composed of a series of
rotor-synchronized p pulses with 15.0 ms pulse widths. There was a two-pulse
phase-modulation (TPPM) decoupling with 100 kHz 1H radiofrequency (rf) field
that was utilized during the t1 and t2 periods. For the PITHIRDS-CT experi-
ments that detected the intermolecular 13C-13C dipole-dipole couplings
(Tycko, 2007), the MAS frequency was set to 20.0 kHz and the 13C p pulses
during the dephasing period were set to 16.7 ms, which was 1/3 of the rotor
period. The pulsed spin locking (PSL) approach was used for the acquisition
period in order to achieve enhancement in the spectral sensitivity (Petkova
and Tycko, 2004). A reduced 1H TPPMdecoupling field of75 kHzwas utilized
during the PSL acquisition time. For the proton-assisted spin diffusion (RAD)
experiments, which provide long-range side-chain or backbone contacts
up to 7 A˚ (Morcombe et al., 2004), a 500 ms mixing period was applied and
the 1H rf field during the mixing period was set to be 10 kHz, which is
close to the MAS frequency. All these 2D experiments were 13C detected.
The 13C chemical shifts were referenced relative to tetramethylsilane, using
the carbonyl signal of L-alanine powder at 177.95 parts per million (ppm) as
an external reference.
Figure 6. Side-Chain Orientations of the
Loop Region Residues
The residues Asn23/Asp23, Ser26, and Lys28
were shown in (A) D23N parallel (PDB ID 2MPZ),
(B) D23N antiparallel (PDB ID 2LNQ), and (C) wild-
type parallel Ab fibrils (PDB ID 2M4J). Solid-state
NMR experimental distance restraints were ob-
tained between specific nuclei within residue pairs
Asn23/Ser26 in model (A) and Asp23/Lys28 in
model (C).
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We used the Rosetta symmetric modeling framework (DiMaio et al., 2011),
customized for optimal sampling of parallel fibril arrangements (see Supple-
mental Experimental Procedures for a complete description of symmetry
parameters and command lines). In general, the use of an explicitly symmetric
representation of the system has two main advantages over conventional
approaches relying on noncrystallographic symmetry restraints to enforce
symmetry during a calculation: (1) the rigid-body parameters of the system
can be manipulated individually, allowing for optimal sampling of confor-
mations consistent with a specified symmetry type; and (2) only a minimum
subset of the full system needs to be considered for energy and derivative
evaluation. Conformational changes are then automatically propagated
among symmetry-related subunits at no additional overhead.
The Rosetta structure calculations were done for the Ab segments 16–40,
as these residues are located in the fibril core based on previous studies
(Paravastu et al., 2008; Petkova et al., 2006). Briefly, the solid-state chemical
shifts were used to select 3- and 9-residue fragments from a database of
high-resolution X-ray structures that was further annotated by predicted
chemical shift values for backbone atoms using the program SPARTA+ (see
Supplemental Experimental Procedures step, fragment selection) (Shen and
Bax, 2010; Vernon et al., 2013). Starting from an array of extended polypeptide
chains arranged around a 3-fold axis of symmetry axis that is parallel to
the main axis of the fibril, we performed symmetric fold-and-dock calculations
using the chemical shift-derived fragments and solid-state NMR restraints
as described previously (Loquet et al., 2012). The fold-and-dock protocol
consists of two main steps. In the first step (‘‘Abinitio’’), performed using a
coarse-grain representation of the system, fragment insertion and rigid-body
Monte Carlo trials are propagated among symmetry-related subunits and
scored using a knowledge-based centroid energy function that favors
collapsed conformations with protein-like features. The second step (‘‘Relax’’)
gradually transforms the previously sampled coarse-grain models into real-
istic, all-atom fibril assemblies in a series of iterations, involving symmetric
side-chain repacking and quasi-Newton minimization of the total energy of
the system, by optimizing all side-chain, backbone, and rigid-body degrees
of freedom. At this final step, we are using a physically realistic, all-atom en-
ergy function (talaris2013). The talaris2013 score function combines several
recent improvements, including the 2010 Dunbrack Rotamer Library, the sp2
hydrogen bond potential, an explicit electrostatics termwith a distance depen-
dent dielectric, the use of bicubic-spline interpolation of all knowledge-based
potentials, an improved disulfide potential, and an analytic evaluation of
Lennard-Jones and EEF1 potentials. The detailed functional form of the
energy function is outlined in detail in previous work (Leaver-Fay et al., 2013;
Song et al., 2011).
We modeled a total of nine trimeric units, helically arranged to yield a
27-subunit fibril. In all calculations, the 3-fold and overall fibril symmetry
parameters (degree rotation and axial displacements per unit layer, plus
radii of the 2- and 3-fold symmetry axes) were sampled according to the
experimental restraints and Rosetta energy function. We computed a total
of 10,000 models with an approximate central processing unit time of
3 min/model.
The following types of experimental distance restraints from solid-state
NMR measurements were used (cf. Table S1): (1) intramolecular backbone
and side-chain contacts from the assigned crosspeaks in 2D 13C-13C spin
diffusion spectra; (2) intermolecular contacts within the trimeric Ab unit located
in the same layer; and (3) quantitative 13C-PITHIRDs-CT distances reporting onStructure 23, 21contacts between adjacent Ab monomers along the fibril axis. All restraints
were implemented using a flat-bottom potential as a parametric function of













where Ix is the cross peak height and I0 the height of the diagonal peak (Man-
olikas et al., 2008). Judged from the spectral noise in the 2D spin diffusion
experiments, which had roughly 10:1 signal-to-noise ratio for the strongest
long-range crosspeak between the Cz of F19 and Cg of L34, our upper-limit











The F19/L34 crosspeak was used as an internal calibration point assuming a
6.5 A˚ distance, as observed in preliminary calculations where all restraints
were assigned a ‘‘generous’’ 10 A˚ upper limit. The average value of sampled
distances for the strongest contact (between the Cz of F19 and Cg of L34)
was then used as an estimate to calibrate the remaining restraints in the final
calculations. This approach prevents over-restraining the calculations to the
NMR data. Given that the majority (>80%) of the final score is determined by
the Rosetta energy terms, the exact upper value did not have a significant
effect on the sampled models. With the exception of a single outlier (V24C’/
G29Ca, cf. Figure S1), the distances obtained in the final models are within
the estimated upper limits. The violation for V24C’/G29Ca is due to severe
signal overlap in the diagonal region for the carbonyl of V24, which prevents
the precise estimation of the upper limit.
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